Literature DB >> 25064786

Hypothermia as a clinical neuroprotectant.

Andrew L Sherman1, Michael Y Wang2.   

Abstract

Applying therapeutic hypothermia (TH) for the purposes of neuroprotection, originally termed "hibernation," started nearly 100 years ago. Because TH cooling systems have improved to the point where it is practical and safe for general application, interest in providing such treatment in conditions such as spinal cord injury, traumatic brain injury, stroke, and cardiac arrest has increased. This article reviews the mechanisms by which TH mitigates secondary neurologic injury, the clinical scenarios where TH is being applied, and reviews selected published studies using TH for central nervous system neuroprotection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ASIA score; Hypothermia; Methylprednisolone; Neuroprotection; Spinal cord injury; Trauma

Mesh:

Year:  2014        PMID: 25064786     DOI: 10.1016/j.pmr.2014.04.003

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  3 in total

1.  Examining potential side effects of therapeutic hypothermia in experimental intracerebral hemorrhage.

Authors:  Shannon Wowk; Kelly J Fagan; Yonglie Ma; Helen Nichol; Frederick Colbourne
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  Hypothermia Reduces Mortality, Prevents the Calcium Plateau, and Is Neuroprotective Following Status Epilepticus in Rats.

Authors:  Kristin F Phillips; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Front Neurol       Date:  2018-06-11       Impact factor: 4.003

3.  In vitro and in vivo evaluation of hypothermia on pharmacokinetics and pharmacodynamics of nimodipine in rabbits.

Authors:  Yu-Xing Fei; Tian-Hong Zhang; Jing Zhao; He Ren; Ya-Nan Du; Chun-Ling Yu; Qiang Wang; Shu Li; Ting-Lin Ren; Qiang Jian; Shu-Yang Fei; Zhen-Qing Zhang; Yi Zhang
Journal:  J Int Med Res       Date:  2017-08-29       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.